{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T15:19:19Z","timestamp":1779895159012,"version":"3.53.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2007,1,13]],"date-time":"2007-01-13T00:00:00Z","timestamp":1168646400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"published-print":{"date-parts":[[2007,3,13]]},"DOI":"10.1007\/s11239-006-0001-9","type":"journal-article","created":{"date-parts":[[2007,1,16]],"date-time":"2007-01-16T19:51:37Z","timestamp":1168977097000},"page":"129-133","source":"Crossref","is-referenced-by-count":8,"title":["Tissue factor and nitric oxide: a controversial relationship!"],"prefix":"10.1007","volume":"23","author":[{"given":"Luci Maria SantAna","family":"Dusse","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan J.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bashir A.","family":"Lwaleed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,1,13]]},"reference":[{"key":"1_CR1","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1182\/blood-2004-09-3567","volume":"105","author":"S Butenas","year":"2005","unstructured":"Butenas S, Bouchart BA, Brummel-Ziedins KE, Parhami-Seren B, Mann KG (2005) Tissue factor activity in whole blood, Blood 105:2764\u20132770","journal-title":"Blood"},{"key":"1_CR2","first-page":"298","volume":"67","author":"B Vallet","year":"2001","unstructured":"Vallet B (2001) Microthrombosis in sepsis. Minerva Anesthesiol 67:298\u2013301","journal-title":"Minerva Anesthesiol"},{"key":"1_CR3","doi-asserted-by":"crossref","first-page":"5148","DOI":"10.1073\/pnas.84.15.5148","volume":"84","author":"EK Spicer","year":"1987","unstructured":"Spicer EK, Horton R, Bloem L et al (1987) Isolation of cDNA clones coding for human tissue factor: primary structure of the protein and cDNA. Proc Natl Acad Sci USA 84:5148\u20135152","journal-title":"Proc Natl Acad Sci USA"},{"key":"1_CR4","first-page":"170","volume":"29","author":"Y Nemerson","year":"1992","unstructured":"Nemerson Y (1992) The tissue factor pathway of blood coagulation. Semin Hematol 29:170\u2013176","journal-title":"Semin Hematol"},{"key":"1_CR5","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1073\/pnas.86.8.2839","volume":"86","author":"JN Wilcox","year":"1989","unstructured":"Wilcox JN, Smith KM, Schwartz SM, Gordon D (1989) Localization of tissue factor in the normal blood vessel wall and in atherosclerotic plaque. Proc Natl Acad Sci USA. 86:2839\u20132843","journal-title":"Proc Natl Acad Sci USA"},{"key":"1_CR6","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.1182\/blood.V89.9.3270","volume":"89","author":"RR Bach","year":"1997","unstructured":"Bach RR, Moldow CF (1997) Mechanism of tissue factor activation on HL-60 cells. Blood 89:3270\u20133276","journal-title":"Blood"},{"key":"1_CR7","first-page":"297","volume":"76","author":"SV Thiruvikraman","year":"1997","unstructured":"Thiruvikraman SV, Guha A, Roboz J, Taubman MB, Nemerson Y, Fallon JT (1997) In situ localization of tissue factor in human atherosclerotic plaques by binding of digoxigenin-labeled factors VIIa and X. Lab Invest 76:297\u2013299","journal-title":"Lab Invest"},{"key":"1_CR8","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/path.1871","volume":"208","author":"BA Lwalled","year":"2006","unstructured":"Lwalled BA, Bass PS (2006) Tissue factor pathway inhibitor: structure, biology and involvement in disease. J Pathol 208:327\u2013339","journal-title":"J Pathol"},{"key":"1_CR9","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/288373a0","volume":"288","author":"RF Furchgott","year":"1980","unstructured":"Furchgott RF, Zawadzki JV (1980) The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acethylcoline. Nature 288:373\u2013376","journal-title":"Nature"},{"key":"1_CR10","first-page":"109","volume":"43","author":"S Moncada","year":"1991","unstructured":"Moncada S, Palmer RMJ, Ferrige G. (1991) Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 43:109\u2013142","journal-title":"Pharmacol Rev"},{"key":"1_CR11","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1097\/00005344-199912000-00016","volume":"34","author":"LJ Ignarro","year":"1999","unstructured":"Ignarro LJ, Cirino G, Casini A, C. Napoli C (1999) Nitric oxide as a signaling molecule in the vascular system: an overview. J Cardiovasc Pharmacol 34:879\u2013886","journal-title":"J Cardiovasc Pharmacol"},{"key":"1_CR12","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/0092-8674(94)90268-2","volume":"78","author":"MA Marletta","year":"1994","unstructured":"Marletta MA (1994) Nitric oxide synthase: aspects concerning structure and catalysis. Cell 78:927\u2013930","journal-title":"Cell"},{"key":"1_CR13","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1365-2796.1994.tb01081.x","volume":"235","author":"A Wennmalm","year":"1994","unstructured":"Wennmalm A (1994) Endothelial nitric oxide and cardiovascular disease. J Int Med 235:317\u2013327","journal-title":"J Int Med"},{"key":"1_CR14","doi-asserted-by":"crossref","first-page":"395","DOI":"10.3109\/07853899509002593","volume":"27","author":"GJ Dusting","year":"1995","unstructured":"Dusting GJ, MacDonald PS (1995) Endogenous nitric oxide in cardiovascular disease and transplantation. Ann Med 27:395\u2013406","journal-title":"Ann Med"},{"key":"1_CR15","doi-asserted-by":"crossref","first-page":"10043","DOI":"10.1073\/pnas.87.24.10043","volume":"87","author":"MW Radomski","year":"1990","unstructured":"Radomski MW, Palmer RM, Moncada S (1990) Glucocorticoids inhibit the expression of an inducible, but not the constitutive nitric oxide synthase in vascular endothelial cells. Proc Natl Acad Sci USA 87:10043\u201310047","journal-title":"Proc Natl Acad Sci USA"},{"key":"1_CR16","doi-asserted-by":"crossref","first-page":"C1424","DOI":"10.1152\/ajpcell.1996.271.5.C1424","volume":"271","author":"JS Beckman","year":"1996","unstructured":"Beckman JS, Koppenol WH (1996) Nitric oxide, superoxide, and peroxinitrite: the good, the bad, and the ugly. Am J Physiol 271:C1424\u2013C1437","journal-title":"Am J Physiol"},{"key":"1_CR17","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S1054-3589(08)61079-0","volume":"34","author":"JP Crow","year":"1995","unstructured":"Crow JP, Beckman JS (1995) Reactions between nitric oxide, superoxide, and peroxinitrite: footprints of peroxinitrite in vivo. Adv Pharmacol 34:17\u201334","journal-title":"Adv Pharmacol"},{"key":"1_CR18","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1161\/01.ATV.17.11.2479","volume":"17","author":"JN Wilcox","year":"1997","unstructured":"Wilcox JN, Subramanian RR, Sundell CL, Tracey WR, Pollock JS (1997) Expression of multiple isoforms of nitric oxide synthase in normal and atherosclerotic vessels. Arterioscl Thromb Vasc Biol 17:2479\u20132488","journal-title":"Arterioscl Thromb Vasc Biol"},{"key":"1_CR19","first-page":"77","volume":"75","author":"LD Buttery","year":"1996","unstructured":"Buttery LD, Springall DR, Chester AH, Evans TJ, Standfield EN (1996) Inducible nitric oxide synthase is present within human atherosclerotic lesions and promotes the formation and activity of peroxynitrite. Lab Invest 75:77\u201385","journal-title":"Lab Invest"},{"issue":"suppl","key":"1_CR20","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1016\/0021-9150(95)90075-6","volume":"118","author":"MW Radomski","year":"1995","unstructured":"Radomski MW, Salas E (1995) Nitric oxide: Biological mediator, modulator and factor of injury; its role in the pathogenesis of atherosclerosis [review]. Atherosclerosis 118(suppl):S69\u2013S80","journal-title":"Atherosclerosis"},{"key":"1_CR21","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1161\/01.CIR.99.9.1236","volume":"99","author":"BY Wang","year":"1999","unstructured":"Wang BY, Ho HK, Lin PS, Schwarzacher SP, Pollman MJ, Gibbons GH (1999) Regression of atherosclerosis: Role of nitric oxide and apoptosis. Circulation 99:1236\u20131241","journal-title":"Circulation"},{"issue":"suppl 4","key":"1_CR22","first-page":"269","volume":"26","author":"V Fuster","year":"1996","unstructured":"Fuster V, Badimon J, Chesebro JH, Fallon JT (1996) Plaque rupture, thrombosis, and therapeutic implications [review]. Haemostasis 26(suppl 4):269\u2013284","journal-title":"Haemostasis"},{"key":"1_CR23","doi-asserted-by":"crossref","first-page":"4738","DOI":"10.1073\/pnas.95.8.4738","volume":"95","author":"A Papapetropoulos","year":"1998","unstructured":"Papapetropoulos A, Piccardoni P, Cirino G et al (1998) Hypotension and inflammatory cytokine gene expression triggered by factor Xa-nitric oxide signaling. Proc Natl Acad Sci USA 95:4738\u20134742","journal-title":"Proc Natl Acad Sci USA"},{"key":"1_CR24","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1007\/s001340050745","volume":"24","author":"M Gerlach","year":"1998","unstructured":"Gerlach M, Keh D, Bezold G et al (1998) Nitric oxide inhibits tissue factor in human monocytes by prior formation of peroxinitrite. Intens Care Med 24:1199\u20131208","journal-title":"Intens Care Med"},{"issue":"3","key":"1_CR25","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1213\/01.ANE.0000101988.62847.0C","volume":"98","author":"VG Nielsen","year":"2004","unstructured":"Nielsen VG, Crow JP (2004) Peroxynitrite dexreases rabbit tissue factor activity in vitro. Anesth Analg 98(3):668\u2013671","journal-title":"Anesth Analg"},{"key":"1_CR26","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1084\/jem.175.5.1181","volume":"175","author":"R Schreck","year":"1992","unstructured":"Schreck R, Meier B, M\u00e4nnel DN, Dr\u00f6ge W, Baeuerle PA (1992) Dithiocarbamates as potent inhibitors of nuclear factor kB activation in intact cells. J Exp Med 175:1181\u20131194","journal-title":"J Exp Med"},{"key":"1_CR27","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1172\/JCI118074","volume":"96","author":"R Caterina De","year":"1995","unstructured":"De Caterina R, Libby P, Peng HB et al (1995) Nitric oxide decreases cytokine-induced endothelial activation: nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest 96:60\u201368","journal-title":"J Clin Invest"},{"key":"1_CR28","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1084\/jem.174.6.1517","volume":"174","author":"N Mackman","year":"1991","unstructured":"Mackman N, Brand K, Edington TS (1991) Lipopolysacharide-mediated transcriptional activation of the human tissue factor gene in THP-1 monocytic cells requires both activator protein 1 and nuclear factor kB binding sites. J Exp Med 174:1517\u20131526","journal-title":"J Exp Med"},{"key":"1_CR29","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0171-2985(11)80342-6","volume":"187","author":"JM M\u00fcller","year":"1993","unstructured":"M\u00fcller JM, Ziegler-Heibrock HWL, Baeuerle PA (1993) Nuclear factor kappa B, a mediator of lipopolysacharide effects. Immunobiology 187:233\u2013256","journal-title":"Immunobiology"},{"key":"1_CR30","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1161\/01.HYP.0000051642.65283.36","volume":"4","author":"K Egashira","year":"2003","unstructured":"Egashira K (2003) Molecular mechanism mediating inflammation in vascular disease: special reference to monocyte chemoattractant protein-1. Hipertensi\u00f3n 4:834\u2013841","journal-title":"Hipertensi\u00f3n"},{"key":"1_CR31","doi-asserted-by":"crossref","first-page":"H1478","DOI":"10.1152\/ajpheart.00739.2001","volume":"282","author":"M Kubo-Inoue","year":"2002","unstructured":"Kubo-Inoue M, Egashira K, Usui M et al (2002) Long term inhibition of nitric oxide synthesis increases arterial thrombogenecity in rat carotid artery. Am J Physiol Heart Circ Physiol 282:H1478\u2013H1484","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"1_CR32","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1161\/01.CIR.101.18.2144","volume":"101","author":"Y Yang","year":"2000","unstructured":"Yang Y, Loscalzo J (2000) Regulation of tissue factor expresi\u00f3n in human microvascular endotelial cells by nitric oxide. Circulation 101:2144\u20132148","journal-title":"Circulation"},{"key":"1_CR33","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1161\/01.ATV.0000178171.61754.cd","volume":"25","author":"T Sakamoto","year":"2005","unstructured":"Sakamoto T, Ishibashi T, Sakamoto N et al (2005) Endogenous NO blockade enhances tissue factos expression via increased Ca2+ influx through MCP-1 in endothelial cells by monocyte adhesion. Artherioscler Thromb Vasc Biol 25:2005\u20132011","journal-title":"Artherioscler Thromb Vasc Biol"},{"key":"1_CR34","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1172\/JCI116234","volume":"91","author":"MB Taubman","year":"1993","unstructured":"Taubman MB, Marmur JD, Rosenfield CL, Guha A, Nichberger S, Nemerson Y. (1993) Agonist-mediated tissue factor expression in cultured vascular smooth muscle cells: role of Ca2\u00a0+ mobilization and protein kinase C activation. J Clin Invest. 91:547\u2013552","journal-title":"J Clin Invest"},{"key":"1_CR35","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1161\/01.CIR.98.17.1776","volume":"98","author":"D Corseaux","year":"1998","unstructured":"Corseaux D, Tourneau TL, Six I et al (1998) Enhanced monocyte tissue factor response after experimental balloon angioplasty in hipercholesterolemic rabbit:inhibition with dietary L-arginine. Circulation. 98:1776\u20131782","journal-title":"Circulation"},{"key":"1_CR36","first-page":"193","volume":"27","author":"B Pollack","year":"1997","unstructured":"Pollack B, Pernod G, Barro C, Doussi\u00e8re J (1997) Role of oxygen radicals in tissue factor induction by endotoxin in blood monocytes. Haemostasis 27:193\u2013200","journal-title":"Haemostasis"},{"key":"1_CR37","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1067\/mva.2003.140","volume":"37","author":"MR Kibbe","year":"2003","unstructured":"Kibbe MR, Johnnides C, Gleixner S et al (2003) Regulation of tissue factor expression in smooth muscle with nitric oxide. J Vasc Surg 37:650\u2013659","journal-title":"J Vasc Surg"},{"key":"1_CR38","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1164\/ajrccm.163.7.2002061","volume":"163","author":"T Kobaiaski","year":"2001","unstructured":"Kobaiaski T, Gabazza EC, Shimuzi S, Yasui H, Yuda H, Hataji O (2001) Long-term inhalation of high dose nitric oxide increases intra alveolar activation of coagulation system in mice. Am J Resp Crit Care Med 163:1676\u20131682","journal-title":"Am J Resp Crit Care Med"},{"key":"1_CR39","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1161\/hh0102.102330","volume":"90","author":"LJ Ignarro","year":"2002","unstructured":"Ignarro LJ, Napoli C, Loscalzo J (2002) Nitric oxide donors and cardiovascular agents modulating the bioactivity of nitric oxide. Circ Res 90:21\u201328","journal-title":"Circ Res"},{"key":"1_CR40","doi-asserted-by":"crossref","first-page":"5245","DOI":"10.4049\/jimmunol.165.9.5245","volume":"165","author":"S Fiorucci","year":"2000","unstructured":"Fiorucci S, Santucci L, Cirino G et al (2000) IL-1 beta converting enzyme is a target for nitric oxide-releasing aspirin: new insights in the anti-inflammatory mechanism of nitric oxide-releasing nonsteroidal anti-inflammatory drugs. J Immunol 165:5245\u20135254","journal-title":"J Immunol"},{"key":"1_CR41","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/sj.bjp.0704326","volume":"134","author":"P Minuz","year":"2001","unstructured":"Minuz P, Degan M, Gaiano S et al (2001) NCX4016 (NO-aspirin) has multiple inhibitory effects in LPS-stimulated human monocytes. Br J Pharmacol 134:905\u2013911","journal-title":"Br J Pharmacol"},{"key":"1_CR42","doi-asserted-by":"crossref","first-page":"3120","DOI":"10.1161\/01.CIR.0000039341.57809.1E","volume":"106","author":"S Fiorucci","year":"2002","unstructured":"Fiorucci S, Mencarelli A, Meneguzzi A et al (2002) NCX-4016 (NO-aspirin) inhibits lipopolysaccharide-induced tissue factor expression in vivo. Role of nitric oxide. Circulation 106:3120\u20133125","journal-title":"Circulation"},{"issue":"22","key":"1_CR43","doi-asserted-by":"crossref","first-page":"8497","DOI":"10.1073\/pnas.0401996101","volume":"101","author":"E Ongini","year":"2004","unstructured":"Ongini E, Impagnatiello F, Bonazzi A et al (2004) Nitric oxide (NO)-releasing statin derivatives, a class of drugs showing enhanced antiproliferative and anti-inflammatory properties. PNAS 101(22):8497\u20138502","journal-title":"PNAS"},{"key":"1_CR44","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1111\/j.1538-7836.2005.01605.x","volume":"3","author":"MR Rossielo","year":"2005","unstructured":"Rossielo MR, Momi S, Caracchini R et al (2005) A novel nitric oxide-releasing statin derivate exerts na antiplatelet\/ antithrombotic activity and inhibits tissue factor expression. J Thromb Haemostasis 3:2554\u20132562","journal-title":"J Thromb Haemostasis"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-006-0001-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11239-006-0001-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-006-0001-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,19]],"date-time":"2020-04-19T19:20:22Z","timestamp":1587324022000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11239-006-0001-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1,13]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,3,13]]}},"alternative-id":["1"],"URL":"https:\/\/doi.org\/10.1007\/s11239-006-0001-9","relation":{},"ISSN":["0929-5305","1573-742X"],"issn-type":[{"value":"0929-5305","type":"print"},{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,1,13]]}}}